Studies comparing neuroendocrine differences between the spontaneously hypertensive rat (SHR) and the normotensive Wistar-Kyoto (WKY) strains have suggested altered anterior pituitary corticotrope expression of POMC associated with the development of hypertension in SHR animals. One major difficulty in comparing the SHR and WKY strains is that the two strains exhibit genetic differences unrelated to blood pressure status, because inbred in the SHR genome is a profile of behavioral characteristics different from those in the WKY, including hyperactivity in a novel environment and hyperreactivity in responding to stress. The present studies examine two new inbred rat strains, the WKHT and WKHA, which independently express the hypertension and behavioral traits, respectively. Together with the SHR and WKY, these genetically related, homozygous strains permit a more definitive means of examining the neuroendocrine correlates of either hypertension or behavior.
A MONG numerous factors, the physiological responses to stress are thought to initiate and sustain a variety of pathological states, including behavioral abnormalities, neurological dysfunction, and cardiovascular disorders. Among many animal models used to study the relationship between stress and the physiological basis of these disorders, the spontaneously hypertensive rat (SHR) has been widely used as a model of essential human hypertension (1, 2). The SHR strain develops hypertension spontaneously between 9 and 15 weeks of age, which subsequently persists throughout life. Inheritance of the hypertensive trait in the SHR is additive, involving multiple genes (3). The hypothalamicpituitary-adrenal axis (HPA) is activated during stress, and among many physiological changes, heightened neuroen-docrine responses including alterations in POMC expression, have been implicated to participate in the hypertensive process in the SHR (4) (5) (6) (7) (8) . Studies have demonstrated that hypophysectomy or adrenalectomy of SHR rats before the onset of hypertension ameliorates the hypertensive process (1, 7). Anterior pituitary gland corticotrope cell populations are altered in the SHR (l), and basal plasma POMC peptide and corticosterone levels exhibit abnormalities in SHR animals during development (7, 9, 10) . SHR rats under a number of stress paradigms display aberrant POMC peptide and corticosterone responses (7, 11) . Furthermore, iv administration of hypothalamic CRH or vasopressin to SHR animals elicits altered ACTH responses compared to those in WKY animals (6, 7, 12) . These observations are consistent with the hypothesis that abnormalities in the HPA axis have central roles in the development of spontaneous hypertension.
It may be inappropriate to attribute all of these changes in the HPA axis to the hypertension in the SHR strain. The SHR is a highly inbred strain and displays numerous other characteristics different from those of the WKY control animals apart from blood pressure. In particular, SHR rats exhibit behavioral differences from WKY rats, including increased spontaneous activity in a novel environment, impaired habituation to novelty, increased cardiovascular and sympatho-adrenal medullary responses to stress, increased avoidance and operant responding, and increased aggression (13) (14) (15) (16) (17) .
Hendley and Ohlsson (18) initiated a recombinant inbreeding program to dissociate the two most prominent characteristics of the SHR strain, hypertension and hyperactivity. Cross-breeding of the SHR and WKY strains followed by selected recombinant inbreeding led to development of the WKHT and WKHA rat strains. WKHT rats are hypertensive, but not hyperactive, whereas WKHA rats are hyperactive, but not hypertensive (18) . Together with the parental strains, SHR, which are both hyperactive and hypertensive, and WKY, which are neither, the four strains were used in the present study to determine neuroendocrine changes in anterior pituitary gland corticotropes associated with either of these two traits. It was hypothesized that changes relevant to hypertension should be observed in SHR and WKHT rats, but not WKY or WKHA rats. Similarly, changes relevant to hyperactivity should be observed in WKHA and SHR rats, but not WKY or WKHT rats. It was reasoned further that because WKHA rats express the hyperreactivity to stress observed in the SHR strain in addition to hyperactivity (19, 20) , any changes in WKHA and SHR relative to the other two strains may also be relevant to hyperreactivity to stress. It should be noted, however, that the WKHA strain does not express some of the other identified behavioral traits of the SHR strain, such as impaired habituation to novelty (18) or aggression (21).
To investigate whether altered anterior pituitary gland POMC expression is associated with hypertension, we examined tissue POMC peptide content, POMC mRNA levels, and corticotrope populations in subjects from the inbred SHR, WKY, WKHA, and WKHT strains. We have identified decreased anterior pituitary gland POMC peptide and mRNA levels and apparent decreases in corticotrope populations in the hypertensive SHR and WKHT rat strains. 
Results
Anterior pituitary POMC peptide levels are decreased in hypertensive rat strains
The levels of the anterior pituitary gland POMC peptides P-endorphin and ACTH were determined using RIA in tissue extracts from male WKY, SHR, WKHA, and WKHT rat at 5-7 weeks of age (weanling prehypertensive) and 5 months of age (adult hypertensive). The levels of P-endorphin immunoreactivity in the adult rat anterior pituitary glands were decreased significantly in the hypertensive strains [F(3,15) = 9.71; P < O.OOl]; levels were reduced 45-50% in the SHR and WKHT strains compared to those in the WKY strain (Fig.  1A) . Anterior pituitary levels of /3-endorphin immunoreactivity in adult WKHA rats were not significantly different from those in the WKY control animals. Corticotrope ACTH immunoreactivity levels were similarly decreased approximately 40% in the WKHT and SHR strains relative to those in the WKY strain [F(3,19) = 56.01; P < 0.001; data not shown].
Hormone content in prehypertensive weanling SHR and WKHT animals was also significantly reduced [F(3,21) = 35.59; P < O.OOl] approximately 30-35% below normotensive WKY levels (Fig. 1B) . Accordingly, a reduction in POMC peptide levels was apparent before the onset of hypertension in the SHR and WKHT strains. In contrast to those in adult tissues, the levels of P-endorphin immunoreactivity were significantly reduced approximately 10% in the anterior pituitary glands of weanling WKHA animals.
In were not altered in SHR animals (34). To assess whether other anterior pituitary peptides with potential functions in blood pressure control were also altered in hypertension, anterior pituitary levels of the vasoregulatory peptide NPY were determined. In contrast to that of the POMC peptides, anterior pituitary NPY content did not differ significantly among the four strains (data not shown). These results demonstrated that the changes in anterior pituitary POMC peptide levels were specific and not a generalized attenuation of anterior pituitary peptide expression in the SHR and WKHT animals.
Anterior pituitary POMC mRNA levels are decreased in hypertensive and hyperactive rat strains
To determine whether the changes in tissue POMC peptide content reflected altered POMC mRNA levels, anterior pituitary gland POMC mRNA expression in the WKY, SHR, WKHA, and WKHT rat strains was assessed using Northern blot analysis. Total RNA from anterior pituitary glands from individual animals of each strain was fractionated, blotted, and hybridized using radiolabeled rat POMC cDNA. The resulting autoradiograms were quantitated using computerassisted densitometry, and the levels of POMC mRNA in each sample were normalized to ribosomal RNA levels. Adult rat anterior pituitary POMC mRNA expression was decreased approximately 45% in the SHR and WKHT strains compared to that in the WKY [F(3,14) = 32.40; P < 0.001; Fig. 21 . The reduced levels of POMC mRNA in the hypertensive strains paralleled the trait-specific changes in POMC peptide content. Anterior pituitary POMC levels in the adult WKHA strain, determined by RIA, were not statistically different from those in the WKY strain. In contrast, POMC mRNA levels in the anterior pituitaries of adult WKHA animals were diminished approximately 30% compared to those in WKY animals (Fig. 2) .
Decreased anterior pituitary gland corticotrope cell numbers are associated with hypertension, whereas increased corticotrope cell numbers are associated with hyperactiuity/hyperreactivity
Immunocytochemical studies were performed to examine the cellular basis for altered anterior pituitary gland POMC peptide content and mRNA expression among the four rat strains. The stained anterior pituitary cells from all four strains were primarily stellate in shape, with dense immunoreactive material at the cell periphery characteristic of anterior pituitary corticotropes. Immunocytochemically stained anterior pituitary corticotropes in adult male tissues from SHR and WKHT rats demonstrated two major differences from WKY animals (Fig. 3) . Firstly, with respect to the apparent relative staining intensity in individual cells, SHR and WKHT corticotropes exhibited a broader range of staining intensities than WKY tissues. Secondly, quantitation of the ACTH-immunoreactive anterior pituitary cells among the four rat strains revealed that the number of corticotropes per unit area of tissue section was reduced in the hypertensive SHR and WKHT animals compared to that in the WKY tissue (Fig. 4A) . Cell numbers were decreased 40-45% relative to those in WKY tissue [F(3,8) = 51.15; P < O.OOl], which is consistent with the decreased levels of anterior pituitary POMC peptides determined by RIA. Taken together, the RIA, Northern blot, and immunocytochemical studies suggested that the decreased anterior pituitary POMC expression in hypertensive animals was a consequence of reduced numbers of corticotropes.
In contrast to SHR and WKHT rats, WKHA exhibited a significant increase in the number of corticotropes in adult anterior pituitary glands. The number of immunoreactive cells in the WKHA tissue was increased approximately 30% compared to that in the WKY control rats. As the POMC peptide levels in adult WKHA anterior pituitary glands, determined by RIA, were not significantly different from The darkfield micrograph reveals an apparent decrease in the number of hybridizing cells in the hypertensive SHR and WKHT strains. Bar = 50 rm.
WKY levels, but the number of corticotropes was increased, it appeared that POMC peptide content per corticotrope was decreased in the WKHA.
POMC mRNA per corticotrope is not changed in hypertensive rats, but is decreased in hyperactive/hyperreactiue rats A number of physiological processes could contribute to the apparent decreased levels of corticotrope ACTH immunoreactivity and cell number in hypertensive SHR and WKHT animals. Although lower anterior pituitary POMC peptide content may be a result of decreased corticotrope number, the diminution could also reflect hypersecretion from increased corticotrope stimulation, leading to decreased pituitary cell peptide content. Chronic stimulation of anterior pituitary corticotrope cells with CRH either in vivo or in vitro has been shown to deplete cellular secretory granules (25, 29, 35) . The degranulation process decreases tissue POMC content and produces an apparent decrease in the corticotrope number observed immunocytochemically.
To determine whether the decreased anterior pituitary POMC peptide levels in the hypertensive rats were the result of either decreased corticotrope number or increased corticotrope secretion, in situ hybridization histochemical studies were initiated, using both isotopic and nonisotopic methods. The enzymatic detection of digoxigenin-labeled probes methods permitted higher cellular resolution for cell enumeration, whereas hybridization with 35S-labeled riboprobes allowed densitometric measurements to assess changes in cellular mRNA levels, The digoxigenin and autoradiographic labeling pattern in the anterior pituitary tissues among the four rat strains determined by in situ hybridization histochemistry were similar to those determined by immunocytochemistry (Fig. 5) . The number of anterior pituitary cells expressing POMC mRNA was decreased approximately 40% in the hypertensive SHR and WKHT rat strains compared to the WKY strain [F(3,12) = 75.64; P < 0.001; Fig. 4B ]; the number of corticotropes in WKHA animals was increased approximately 30%. The changes in corticotrope cell numbers observed by in situ hybridization histochemistry correlated well with the immunocytochemical studies. Combined, these studies suggest that the decreased anterior pituitary POMC expression associated with the hypertensive trait was not a reflection of hypersecretory processes, but may result primarily from decreased corticotrope cell numbers.
Although the number of corticotropes was elevated in adult WKHA animals, the levels of POMC peptides were similar to those observed in WKY rats, and POMC mRNA expression was reduced. The relative changes in POMC mRNA levels in individual corticotropes in tissue sections hybridized to 35S-radiolabeled riboprobes among the four strains were quantitated using autoradiographic densitometric methods. The cell population profiles, as a function of integrated optical density, were similar for WKY, SHR, and WKHT cells (Fig. 6) . In contrast, the cell population profiles were shifted to lower optical densities in WKHA tissues, (Fig. 6) , supporting the hypothesis that the decreased POMC expression in the anterior pituitaries from the hypertensive strains were primarily a result of changes in the population of corticotropes.
On the other hand, the mean POMC mRNA per corticotrope in the WKHA strain was decreased approximately 35% compared to that in the WKY, SHR, and WKHT strains (Fig. 6) .
Discussion
Despite early studies implicating defects in the HPA axis in the ontogenesis of hypertension, there has been little consensus on the role of the POMC system in the development of hypertension.
Hypophysectomy or adrenalectomy before the onset of hypertension has been shown to ameliorate hypertension in SHR animals (1, 7 expressing POMC mRNA were examined using in situ hybridization histochemistry.
In the hypertensive animals, the POMC mRNA-expressing corticotrope populations were decreased in parallel with the cell population expressing POMC peptide immunoreactivities.
Thus, the decreased corticotrope populations identified immunocytochemically were not biased by hypersecretory events, and the reduction in the corticotrope population may have contributed to the decreased anterior pituitary POMC expression associated with the hypertensive trait. The broader range of corticotrope POMC peptide immunoreactivity staining intensities in the SHR and WKHT animals, however, may reflect altered corticotrope secretory patterns in the hypertensive rat strains and will require further regulatory studies. In contrast to the present study, Hausler et al. (37) demonstrated no change in the volume density of ACTH-immunoreactive cells between WKY and SHR strains. However, these studies examined the volume density of ACTH-immunoreactive cells in 4-weekold prehypertensive SHR animals, whereas our morphological studies examined cell numbers per tissue unit area in 6-month-old hypertensive animals, which may contribute to the apparent differences between the two studies.
Although POMC peptide levels in the anterior pituitary glands of adult WKHA animals were not significantly different from WKY levels, the population of corticotropes was increased in both the immunocytochemical and in situ hybridization histochemistry studies. Furthermore, tissue and cellular POMC mRNA levels were decreased in the anterior pituitary of WKHA compared to WKY. Homeostatic regulatory mechanisms may be involved in the maintenance of tissue POMC production levels by regulating biosynthesis in a larger population of corticotrope cells; this may play a role in the hyperactivity/hyperreactivity to stress responses observed in the WKHA strain. The mechanisms underlying these processes will require additional studies of corticotrope POMC expression, biosynthesis, and secretion in the WKHA strain under normal and stress conditions. Several physiological studies have demonstrated abnormal corticotrope responsiveness to hypothalamic regulators in SHR animals. Intravenous injection of CRH elicits lower plasma ACTH levels in SHR animals compared to WKY rats, although there are no apparent differences in anterior pituitary gland CRH receptor binding between the two strains (6, 7, 12, 43) . Although the blunted corticotrope ACTH response to the releasing factor CRH observed in adult SHR animals could be interpreted as a consequence of a reduced corticotrope population resulting in a diminished maximal stimulatory ACTH response, the reduced ACTH response to CRH in the SHR has been suggested to be associated with the hyperactivity/hyperreactivity trait (43). The mechanisms underlying these changes in corticotrope reponses to hypothalamic factors will require further examination of the four strains.
The developmental and physiological events that alter anterior pituitary corticotrope function in the hypertensive SHR and WKHT strains remain unclear. Our current results are consistent with suggestions that the abnormal corticotrope responses may be secondary to augmented adrenal function in hypertension.
Pituitary corticotrope function is tightly regulated by circulating corticosteroids in negative feedback pathways to the pituitary gland and central nervous system (44). Corticotropes chronically treated with glucocorticoids or dexamethasone in vivo or in vitro exhibit diminished POMC peptide production and transcription of POMC mRNA (44-48). Compared to the WKY strain, prehypertensive SHR animals display earlier expression of plasma corticosterone during development (6, 7, 9-11). Young SHR animals exhibit elevated baseline levels of corticosterone and greater corticosterone responses to stress (6, 7, 10) . Several considerations suggest that the elevated plasma corticosterone levels in young SHR animals may have significant consequences on the developing HPA axis and the hypertensive process. Along with other endocrine systems, the HPA axis undergoes rapid developmental changes during the first 2 weeks of life in the rat, and the functional capacity to respond to stressors or physiological regulators is present throughout development, exhibiting age and stressor/regulator specificity (49, 50). As adult levels of glucocorticoid receptors are present in neonatal rat pituitary glands, corticotropes exhibit increased steroid sensitivity (45). Furthermore, low circulating levels of corticosterone-binding globulin in neonatal animals may also result in higher circulating levels of free steroid, thereby enhancing the inhibitory feedback process on the HPA axis during development (51). Inappropriate or transient changes in plasma corticosterone levels in developing animals have thus been implicated to elicit dramatic long term effects on a variety of neuroendocrine functions. Whether elevated corticosterone from hyperfunctioning adrenal cortical cells is involved in the altered corticotrope development in the hypertensive SHR and WKHT strains will require further study. The decreased corticotrope population and POMC expression in the SHR and WKHT animals are consistent with inhibitory regulatory mechanisms and concur with studies suggesting adrenal function defects in hypertensive animals. The physiological events leading to augmented adrenal function and elevated corticosterone production during development of hypertension await more detailed study. The altered accelerated development of adrenal cortical function in the SHR has been suggested to be a consequence of increased hypothalamic CRH expression and anterior pituitary corticotrope POMC peptide production in the developing animal (7). Sustained activation of the adrenal cortex may subsequently contribute to the physiological changes leading to the development of hypertension. In contrast, other studies have suggested that glucocorticoid and mineralocorticoid receptor function are altered in some strains of hypertensive rats (52,53). Whether steroid receptor dysfunction, variations in steroid receptor expression, or changes in adrenal cortical function contribute to altered anterior pituitary POMC production and blood pressure control remains uncertain. Additional studies of the hypothalamic-pituitary-adrenal axis in the hypertensive rat strains during development may clarify some of these issues.
The present studies demonstrate that altered anterior pituitary corticotrope function is correlated with hypertension and that the reductions in tissue POMC expression most Endo. 1994 Voll34. No 1 likely reflect decreased corticotrope cell numbers. The four strains of rats have allowed identification of specific changes associated with the hypertensive and hyperactive traits. Further studies using these animals should help define the contributions of altered hypothalamic-pituitary-adrenal function to the hypertensive process.
